title: Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.
authors.affiliation: cr2163@stanford.edu.
authors.forename: Carolyn I
authors.initials: CI
authors.lastname: Rodriguez
authors.forename: Amanda
authors.initials: A
authors.lastname: Levinson
authors.forename: Jordana
authors.initials: J
authors.lastname: Zwerling
authors.forename: Donna
authors.initials: D
authors.lastname: Vermes
authors.forename: Helen Blair
authors.initials: HB
authors.lastname: Simpson
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D039721:Diagnostic and Statistical Manual of Mental Disorders; D057915:Drug Substitution / Q000379:methods; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008559:Memantine / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000188:drug therapy; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
chemical_list: D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D008559:Memantine